|
1
|
Tanoue LT, Tanner NT, Gould MK and
Silvestri GA: Lung cancer screening. Am J Respir Crit Care Med.
191:19–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
An Q, Pacyna-Gengelbach M, Schlüns K,
Deutschmann N, Guo S, Gao Y, Zhang J, Cheng S and Petersen I:
Identification of differentially expressed genes in immortalized
human bronchial epithelial cell line as a model for in vitro study
of lung carcinogenesis. Int J Cancer. 103:194–204. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng TD, Cramb SM, Baade PD, Youlden DR,
Nwogu C and Reid ME: The international epidemiology of lung cancer:
Latest trends, disparities, and tumor characteristics. J Thorac
Oncol. 11:1653–1671. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liao BC, Shao YY, Chen HM, Shau WY, Lin
ZZ, Kuo RN, Lai CL, Chen KH, Cheng AL, Yang JC and Lai MS:
Comparative effectiveness of first-line platinum-based chemotherapy
regimens for advanced lung squamous cell carcinoma. Clin Lung
Cancer. 16:137–143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Travis WD: Pathology of lung cancer. Clin
Chest Med. 32:669–692. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mizoguchi K, Nakamura Y, Sano K, Sato S,
Ikegami Y, Motoshima K, Takemoto S, Ogawara D, Senju H, Sugasaki N,
et al: Pharmacokinetic parameters of gefitinib predict efficacy and
toxicity in patients with advanced non-small cell lung cancer
harboring EGFR mutations. Cancer Chemother Pharmacol. 78:377–382.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Dormady SP and Basch RS:
Identification of four human cDNAs that are differentially
expressed by early hematopoietic progenitors. Exp Hematol.
28:1286–1296. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Andersson S, Wallin KL, Hellström AC,
Morrison LE, Hjerpe A, Auer G, Ried T, Larsson C and
Heselmeyer-Haddad K: Frequent gain of the human telomerase gene
TERC at 3q26 in cervical adenocarcinomas. Br J Cancer. 95:331–338.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang YC, Shyong WY, Chang MS, Chen YJ, Lin
CH, Huang ZD, Wang, Hsu MT and Chen ML: Frequent gain of copy
number on the long arm of chromosome 3 in human cervical
adenocarcinoma. Cancer Genet Cytogenet. 131:48–53. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Kalkum M, Chait BT and Roeder RG:
The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the
JNK pathway through the integral subunit GPS2. Mol Cell. 9:611–623.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perissi V, Aggarwal A, Glass CK, Rose DW
and Rosenfeld MG: A corepressor/coactivator exchange complex
required for transcriptional activation by nuclear receptors and
other regulated transcription factors. Cell. 116:511–526. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Choi HK, Choi KC, Yoo JY, Song M, Ko SJ,
Kim CH, Ahn JH, Chun KH, Yook JI and Yoon HG: Reversible
SUMOylation of TBL1-TBLR1 regulates β-catenin-mediated Wnt
signaling. Mol Cell. 43:203–216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoberg JE, Yeung F and Mayo MW: SMRT
derepression by the IkappaB kinase alpha: A prerequisite to
NF-kappaB transcription and survival. Mol Cell. 16:245–255. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J and Wang CY: TBL1-TBLR1 and
beta-catenin recruit each other to Wnt target-gene promoter for
transcription activation and oncogenesis. Nat Cell Biol.
10:160–169. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Ou J, Guo Y, Dai T, Li X, Liu J,
Xia M, Liu L and He M: TBLR1 is a novel prognostic marker and
promotes epithelial-mesenchymal transition in cervical cancer. Br J
Cancer. 111:112–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Liang W, Liu J, Lin C, Wu S, Song L
and Yuan Z: Transducin (β)-like 1 X-linked receptor 1 promotes
proliferation and tumorigenicity in human breast cancer via
activation of beta-catenin signaling. Breast Cancer Res.
16:4652014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen SP, Yang Q, Wang CJ, Zhang LJ, Fang
Y, Lei FY, Wu S, Song LB, Guo X and Guo L: Transducin β-like 1
X-linked receptor 1 suppresses cisplatin sensitivity in
nasopharyngeal carcinoma via activation of NF-κB pathway. Mol
Cancer. 13:1952014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuang X, Zhu J, Peng Z, Wang J and Chen Z:
Transducin (Beta)-like 1 X-linked receptor 1 correlates with
clinical prognosis and epithelial-mesenchymal transition in
hepatocellular carcinoma. Dig Dis Sci. 61:489–500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Sun W, Zhang K, Zheng H, Ma Y, Lin
D, Zhang X, Feng L, Lei W, Zhang Z, et al: Identification of genes
differentially expressed in human primary lung squamous cell
carcinoma. Lung Cancer. 56:307–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan J, Gumireddy K, Li A and Huang Q:
Regulation of mesenchymal phenotype by MicroRNAs in cancer. Curr
Cancer Drug Targets. 13:930–934. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giannelli G, Bergamini C, Fransvea E,
Sgarra C and Antonaci S: Laminin-5 with transforming growth
factor-beta1 induces epithelial to mesenchymal transition in
hepatocellular carcinoma. Gastroenterology. 129:1375–1383. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li N, Xu H, Fan K, Liu X, Qi J, Zhao C,
Yin P, Wang L, Li Z and Zha X: Altered beta1,6-GlcNAc branched
N-glycans impair TGF-β-mediated epithelial-to-mesenchymal
transition through Smad signalling pathway in human lung cancer. J
Cell Mol Med. 18:1975–1991. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang G, Liang Y, Zheng T, Song R, Wang J,
Shi H, Sun B, Xie C, Li Y, Han J, et al: FCN2 inhibits
epithelial-mesenchymal transition-induced metastasis of
hepatocellular carcinoma via TGF-β/Smad signaling. Cancer Lett.
378:80–86. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L,
Jiang H, Ren J, Cai J and Li Q: Resveratrol suppresses
epithelial-to-mesenchymal transition in colorectal cancer through
TGF-β1/Smads signaling pathway mediated Snail/E-cadherin
expression. BMC Cancer. 15:972015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z and Zhang HT: Long non-coding RNA
XIST promotes TGF-β-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Daniels G, Li Y, Gellert LL, Zhou A,
Melamed J, Wu X, Zhang X, Zhang D, Meruelo D, Logan SK, et al:
TBLR1 as an androgen receptor (AR) coactivator selectively
activates AR target genes to inhibit prostate cancer growth. Endocr
Relat Cancer. 21:127–142. 2013. View Article : Google Scholar
|
|
28
|
Liu F, He Y, Cao Q, Liu N and Zhang W:
TBL1XR1 is highly expressed in gastric cancer and predicts poor
prognosis. Dis Markers. 2016:24365182016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Bio. 15:178–196. 2014. View
Article : Google Scholar
|
|
31
|
Zhai B, Yan HX, Liu SQ, Chen L, Wu MC and
Wang HY: Reduced expression of E-cadherin/catenin complex in
hepatocellular carcinomas. World J Gastroentero. 14:5665–5673.
2008. View Article : Google Scholar
|
|
32
|
Zhai X, Zhu H, Wang W, Zhang S, Zhang Y
and Mao G: Abnormal expression of EMT-related proteins, S100A4,
vimentin and E-cadherin, is correlated with clinicopathological
features and prognosis in HCC. Med Oncol. 31:9702014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee TK, Poon RT, Yuen AP, Ling MT, Kwok
WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL and Fan ST: Twist
overexpression correlates with hepatocellular carcinoma metastasis
through induction of epithelial-mesenchymal transition. Clin Cancer
Res. 12:5369–5376. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guarino M: Epithelial-mesenchymal
transition and tumour invasion. Int J Biochem Cell Biol.
39:2153–2160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu H, Wang M, Wang H, Liu Z, Guan X, Yang
R, Huang R, Tang Q, Zou C, Wang G, et al: MEGF6 promotes the
epithelial-to-mesenchymal transition via the TGFβ/SMAD signaling
pathway in colorectal cancer metastasis. Cell Physiol Biochem.
46:1895–1906. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jung B, Staudacher JJ and Beauchamp D:
Transforming growth factor β superfamily signaling in development
of colorectal cancer. Gastroenterology. 152:36–52. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsang KJ, Tsang D, Brown TN and Crowe DL:
A novel dominant negative Smad2 mutation in a TGFbeta resistant
human carcinoma cell line. Anticancer Res. 22:13–19.
2002.PubMed/NCBI
|
